Filing Details
- Accession Number:
- 0000899243-18-022295
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2018-08-14 16:35:26
- Reporting Period:
- 2017-07-05
- Accepted Time:
- 2018-08-14 16:35:26
- Original Submission Date:
- 2017-07-05
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1420565 | Aileron Therapeutics Inc | ALRN | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1709654 | Scott Kapnick | C/O Aileron Therapeutics, Inc. 281 Albany Street Cambridge MA 02139 | Yes | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-07-05 | 66,666 | $15.00 | 66,666 | No | 4 | P | Indirect | See Footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | See Footnote |
Footnotes
- The amount of securities previously reported as beneficially owned by the Reporting Person inadvertently aggregated shares that the Reporting Person indirectly beneficially owned with shares that the Reporting Person directly beneficially owned following the transaction reported on the original Form 4. The correct number of shares that the Reporting Person indirectly beneficially owned following this transaction was 66,666 shares.
- These shares are directly owned by Jake86 LLC, for which the Reporting Person serves as investment manager. The Reporting Person disclaims beneficial ownership of the shares held by Jake86 LLC, except to the extent of his indirect pecuniary interest therein.